4 minute read
Apr. 2, 2023

QR-6401: An Attempt at AI for Macrocycles

QR-6401

oral, macrocyclic CDK2 inhibitor robust activity in ovarian cancer xenograft models AI generative modeling + opt. ACS. Med. Chem. Lett., February 8, 2023 Regor Therapeutics Group, Shanghai, CN

drughunter.com
Drug Hunter Team
Loading...

twitterlinkedinemail

Other molecules you may be interested in